This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Block & Leviton LLP Investigates Atossa Genetics, Inc. For Possible Violations Of The Federal Securities Laws





BOSTON, Oct. 8, 2013 /PRNewswire/ -- Shares in Atossa Genetics, Inc. (NASDAQ: ATOS) plunged on Monday when the company revealed that it was recalling its ForeCyte Breast Health Test and its Mammary Aspiration Specimen Cytology Tests from the markets.  The reason for the recall is that the U.S. Food and Drug Administration raised concerns about the products.  The Wall Street Journal reports that these concerns were made known to Atossa Genetics in a warning letter from earlier this year. 

Block & Leviton LLP ( www.blockesq.com), a Boston-based law firm representing investors nationwide, is investigating possible securities law violations involving Atossa Genetics. The company's stock price plunged by more than 46% on October 7, 2013 on the news of the recall. 

Block & Leviton's investigation seeks to determine, among other things, whether Atossa Genetics or its officers and directors have violated the federal securities laws.  If you have any information relevant to this investigation, or have questions about your legal rights, please contact attorney Steven P. Harte or Whitney Street of Block & Leviton LLP at (617) 398-5600 or at Steven@blockesq.com or Whitney@blockesq.com.  Confidentiality to any whistleblowers or other persons with information relevant to the investigation is assured.

Block & Leviton is a Boston-based law firm representing investors for violations of securities laws.  The firm's lawyers have collectively been prosecuting securities cases on behalf of investors for over 50 years.

This notice may constitute attorney advertising.Contact:          BLOCK & LEVITON LLP Steven Harte, Esq. Whitney E. Street, Esq.(617) 398-5600 Steven@blockesq.com Whitney@blockesq.com

SOURCE Block & Leviton LLP

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 17,928.20 -142.20 -0.79%
S&P 500 2,089.46 -25.03 -1.18%
NASDAQ 4,939.3270 -77.6020 -1.55%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs